These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 27349252)

  • 81. Strategies for the management of OHSS: Results from freezing-all cycles.
    Borges E; Braga DP; Setti AS; Vingris LS; Figueira RC; Iaconelli A
    JBRA Assist Reprod; 2016 Mar; 20(1):8-12. PubMed ID: 27203299
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
    Kummer NE; Feinn RS; Griffin DW; Nulsen JC; Benadiva CA; Engmann LL
    Hum Reprod; 2013 Jan; 28(1):152-9. PubMed ID: 23077235
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF/ICSI cycles.
    Zhang J; Wang Y; Mao X; Chen Q; Hong Q; Cai R; Zhang S; Kuang Y
    Reprod Biomed Online; 2017 Dec; 35(6):701-707. PubMed ID: 28993105
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves
    Mutlu I; Demirdag E; Cevher F; Erdem A; Erdem M
    J Obstet Gynaecol; 2022 Jul; 42(5):1239-1244. PubMed ID: 34565274
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Risk factors for poor oocyte yield and oocyte immaturity after GnRH agonist triggering.
    Gambini S; Sonigo C; Robin G; Cedrin-Durnerin I; Vinolas C; Sifer C; Boumerdassi Y; Mayeur A; Gallot V; Grynberg M; Peigné M
    Hum Reprod; 2024 May; 39(5):963-973. PubMed ID: 38452353
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.
    Castillo JC; Haahr T; Martínez-Moya M; Humaidan P
    Ups J Med Sci; 2020 May; 125(2):131-137. PubMed ID: 32366146
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: Analysis of 10,427 IVF-ICSI cycles.
    Gunnala V; Melnick A; Irani M; Reichman D; Schattman G; Davis O; Rosenwaks Z
    PLoS One; 2017; 12(4):e0176019. PubMed ID: 28441461
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Long-acting gonadotropin-releasing hormone agonist trigger in fertility preservation cycles before chemotherapy.
    Massarotti C; Stigliani S; Gazzo I; Lambertini M; Anserini P
    ESMO Open; 2023 Aug; 8(4):101597. PubMed ID: 37421801
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study.
    Haas J; Ophir L; Barzilay E; Machtinger R; Yung Y; Orvieto R; Hourvitz A
    Fertil Steril; 2016 Sep; 106(3):653-659.e1. PubMed ID: 27341989
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients.
    Christ J; Herndon CN; Yu B
    J Assist Reprod Genet; 2021 Mar; 38(3):751-756. PubMed ID: 33471229
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Triggering with 1,500 IU of human chorionic gonadotropin plus follicle-stimulating hormone compared to a standard human chorionic gonadotropin trigger dose for oocyte competence in in vitro fertilization cycles: a randomized, double-blinded, controlled noninferiority trial.
    Anaya Y; Cakmak H; Mata DA; Letourneau J; Zhang L; Lenhart N; Juarez-Hernandez F; Jalalian L; Cedars MI; Rosen M
    Fertil Steril; 2022 Aug; 118(2):266-278. PubMed ID: 35705380
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.
    Abbara A; Jayasena CN; Christopoulos G; Narayanaswamy S; Izzi-Engbeaya C; Nijher GM; Comninos AN; Peters D; Buckley A; Ratnasabapathy R; Prague JK; Salim R; Lavery SA; Bloom SR; Szigeti M; Ashby DA; Trew GH; Dhillo WS
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3322-31. PubMed ID: 26192876
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist.
    Kummer N; Benadiva C; Feinn R; Mann J; Nulsen J; Engmann L
    Fertil Steril; 2011 Jul; 96(1):63-8. PubMed ID: 21565337
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome--a 20-year experience.
    Kol S; Itskovitz-Eldor J
    Semin Reprod Med; 2010 Nov; 28(6):500-5. PubMed ID: 21082509
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Symposium: Update on prediction and management of OHSS. Prevention of OHSS: GnRH agonist versus HCG to trigger ovulation.
    Kol S; Dor J
    Reprod Biomed Online; 2009 Jul; 19(1):59-60. PubMed ID: 19573291
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Combined ovulation triggering with GnRH agonist and hCG in IVF patients.
    Kasum M; Kurdija K; Orešković S; Čehić E; Pavičić-Baldani D; Škrgatić L
    Gynecol Endocrinol; 2016 Nov; 32(11):861-865. PubMed ID: 27275861
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Combination of cabergoline and embryo cryopreservation after GnRH agonist triggering prevents OHSS in patients with extremely high estradiol levels--a retrospective study.
    Lin YH; Huang MZ; Hwang JL; Chen HJ; Hsieh BC; Huang LW; Tzeng CR; Seow KM
    J Assist Reprod Genet; 2013 Jun; 30(6):753-9. PubMed ID: 23606010
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
    Griesinger G; Schultz L; Bauer T; Broessner A; Frambach T; Kissler S
    Fertil Steril; 2011 May; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
    [TBL] [Abstract][Full Text] [Related]  

  • 99. New algorithm for OHSS prevention.
    Papanikolaou EG; Humaidan P; Polyzos N; Kalantaridou S; Kol S; Benadiva C; Tournaye H; Tarlatzis B
    Reprod Biol Endocrinol; 2011 Nov; 9():147. PubMed ID: 22054506
    [TBL] [Abstract][Full Text] [Related]  

  • 100. GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis.
    Engmann L; Benadiva C; Humaidan P
    Reprod Biomed Online; 2016 Mar; 32(3):274-85. PubMed ID: 26803205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.